Ben Coleman

Ben Coleman, Ph.D., currently serves as a Personalized Medicine Scientist in Molecular Oncology at Sarah Cannon Research Institute, a position held since July 2023. Prior to this role, Ben was employed as a Senior Analyst and Analyst at Proactive Worldwide from January 2022 to July 2023. Ben's academic background includes a Doctor of Philosophy in Pharmacology from Vanderbilt University, where a dissertation was completed under the guidance of Dr. Brad Grueter from August 2016 to December 2021. Earlier experience includes a Research Technician I position at UT Southwestern Medical Center, focusing on memory enhancement through small interfering peptides, and involvement as an Undergraduate Researcher at Virginia Tech, leading a project on ovarian cancer spheroid formation. Ben holds a Bachelor of Science from Virginia Tech, completed in 2015.